Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novartis’ rare renal disease candidate shows promise in phase II

pharmatimesOctober 29, 2020

Tag: Novartis , iptacopan , C3G , Renal Disease

PharmaSources Customer Service